Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.880
+0.100 (3.60%)
Jan 22, 2026, 3:04 PM EST - Market open
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $135.73 million as of January 22, 2026. Its market cap has increased by 68.92% in one year.
Market Cap
135.73M
Enterprise Value
-28.28M
1-Year Change
68.92%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $135.73M, a decrease of -74.90%. That is a compound annual growth rate of -26.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 131.02M | 14.88% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 138.05M |
| Oramed Pharmaceuticals | 136.92M |
| Turn Therapeutics | 136.63M |
| Actuate Therapeutics | 136.32M |
| Seres Therapeutics | 136.15M |
| Fate Therapeutics | 136.12M |
| Sutro Biopharma | 134.61M |
| Spero Therapeutics | 132.96M |